Risk of urinary tract infections associated with SGLT2 inhibitor use in patients with RA: a target trial emulation study.

Dobashi N, Sada KE, Kudo M, Morishita S, Sasaki S, Suganuma N

Open source

DOI
10.1093/rheumatology/keaf580
Published
2026 Feb 4
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keaf580,
  title = {Risk of urinary tract infections associated with SGLT2 inhibitor use in patients with RA: a target trial emulation study.},
  author = {Dobashi N and Sada KE and Kudo M and Morishita S and Sasaki S and Suganuma N},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keaf580},
  url = {https://doi.org/10.1093/rheumatology/keaf580}
}

RIS

TY  - JOUR
TI  - Risk of urinary tract infections associated with SGLT2 inhibitor use in patients with RA: a target trial emulation study.
AU  - Dobashi N
AU  - Sada KE
AU  - Kudo M
AU  - Morishita S
AU  - Sasaki S
AU  - Suganuma N
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keaf580
UR  - https://doi.org/10.1093/rheumatology/keaf580
ER  - 

APA

N, D., KE, S., M, K., S, M., S, S., & N, S. (2026). Risk of urinary tract infections associated with SGLT2 inhibitor use in patients with RA: a target trial emulation study.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keaf580

Source records